Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.

IgM, IgG, and IgA Influenza-Specific Plasma Cells Express Divergent Transcriptomes.

Price MJ, Hicks SL, Bradley JE, Randall TD, Boss JM, Scharer CD.

J Immunol. 2019 Sep 9. pii: ji1900285. doi: 10.4049/jimmunol.1900285. [Epub ahead of print]

PMID:
31501259
2.

Epigenetic programming underpins B cell dysfunction in human SLE.

Scharer CD, Blalock EL, Mi T, Barwick BG, Jenks SA, Deguchi T, Cashman KS, Neary BE, Patterson DG, Hicks SL, Khosroshahi A, Eun-Hyung Lee F, Wei C, Sanz I, Boss JM.

Nat Immunol. 2019 Aug;20(8):1071-1082. doi: 10.1038/s41590-019-0419-9. Epub 2019 Jul 1.

PMID:
31263277
3.

Stereosonic vision: Exploring visual-to-auditory sensory substitution mappings in an immersive virtual reality navigation paradigm.

Massiceti D, Hicks SL, van Rheede JJ.

PLoS One. 2018 Jul 5;13(7):e0199389. doi: 10.1371/journal.pone.0199389. eCollection 2018.

4.

Effect of Chronic Social Stress on Prenatal Transfer of Antitetanus Immunity in Captive Breeding Rhesus Macaques (Macaca mulatta).

Stammen RL, Cohen JK, Meeker TL, Crane MM, Amara RR, Hicks SL, Meyer JS, Ethun KF.

J Am Assoc Lab Anim Sci. 2018 Jul 1;57(4):357-367. doi: 10.30802/AALAS-JAALAS-17-000102. Epub 2018 May 15.

5.

Struck: Structured Output Tracking with Kernels.

Hare S, Golodetz S, Saffari A, Vineet V, Cheng MM, Hicks SL, Torr PH.

IEEE Trans Pattern Anal Mach Intell. 2016 Oct;38(10):2096-109. doi: 10.1109/TPAMI.2015.2509974. Epub 2015 Dec 17.

PMID:
26700968
6.

Eye-tracking in amyotrophic lateral sclerosis: A longitudinal study of saccadic and cognitive tasks.

Proudfoot M, Menke RA, Sharma R, Berna CM, Hicks SL, Kennard C, Talbot K, Turner MR.

Amyotroph Lateral Scler Frontotemporal Degener. 2015;17(1-2):101-11. doi: 10.3109/21678421.2015.1054292. Epub 2015 Aug 27.

7.

Improving Mobility Performance in Low Vision With a Distance-Based Representation of the Visual Scene.

van Rheede JJ, Wilson IR, Qian RI, Downes SM, Kennard C, Hicks SL.

Invest Ophthalmol Vis Sci. 2015 Jul;56(8):4802-9. doi: 10.1167/iovs.14-16311.

PMID:
26218908
8.

An eye-tracking version of the trail-making test.

Hicks SL, Sharma R, Khan AN, Berna CM, Waldecker A, Talbot K, Kennard C, Turner MR.

PLoS One. 2013 Dec 18;8(12):e84061. doi: 10.1371/journal.pone.0084061. eCollection 2013.

9.

S(+)-ibuprofen destabilizes MYC/MYCN and AKT, increases p53 expression, and induces unfolded protein response and favorable phenotype in neuroblastoma cell lines.

Ikegaki N, Hicks SL, Regan PL, Jacobs J, Jumbo AS, Leonhardt P, Rappaport EF, Tang XX.

Int J Oncol. 2014 Jan;44(1):35-43. doi: 10.3892/ijo.2013.2148. Epub 2013 Oct 25.

10.

A depth-based head-mounted visual display to aid navigation in partially sighted individuals.

Hicks SL, Wilson I, Muhammed L, Worsfold J, Downes SM, Kennard C.

PLoS One. 2013 Jul 3;8(7):e67695. doi: 10.1371/journal.pone.0067695. Print 2013.

11.

Transient treatment with epigenetic modifiers yields stable neuroblastoma stem cells resembling aggressive large-cell neuroblastomas.

Ikegaki N, Shimada H, Fox AM, Regan PL, Jacobs JR, Hicks SL, Rappaport EF, Tang XX.

Proc Natl Acad Sci U S A. 2013 Apr 9;110(15):6097-102. doi: 10.1073/pnas.1118262110. Epub 2013 Mar 11.

12.

On the origin of oscillopsia during pedunculopontine stimulation.

Jenkinson N, Brittain JS, Hicks SL, Kennard C, Aziz TZ.

Stereotact Funct Neurosurg. 2012;90(2):124-9. doi: 10.1159/000335871. Epub 2012 Mar 2.

PMID:
22398800
13.

Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data.

Tabrizi SJ, Reilmann R, Roos RA, Durr A, Leavitt B, Owen G, Jones R, Johnson H, Craufurd D, Hicks SL, Kennard C, Landwehrmeyer B, Stout JC, Borowsky B, Scahill RI, Frost C, Langbehn DR; TRACK-HD investigators.

Lancet Neurol. 2012 Jan;11(1):42-53. doi: 10.1016/S1474-4422(11)70263-0. Epub 2011 Dec 2.

PMID:
22137354
14.

Clinical impairment in premanifest and early Huntington's disease is associated with regionally specific atrophy.

Scahill RI, Hobbs NZ, Say MJ, Bechtel N, Henley SM, Hyare H, Langbehn DR, Jones R, Leavitt BR, Roos RA, Durr A, Johnson H, Lehéricy S, Craufurd D, Kennard C, Hicks SL, Stout JC, Reilmann R, Tabrizi SJ; TRACK-HD investigators.

Hum Brain Mapp. 2013 Mar;34(3):519-29. doi: 10.1002/hbm.21449. Epub 2011 Nov 18.

PMID:
22102212
15.

Erratum to "Visual activation of extra-striate cortex in the absence of V1 activation" [Neuropsychologia 48/14 (2010) 4148-4154].

Bridge H, Hicks SL, Xie J, Okell TW, Mannan S, Alexander I, Cowey A, Kennard C.

Neuropsychologia. 2011 Apr;49(5):1388. doi: 10.1016/j.neuropsychologia.2011.02.043. Epub 2011 Mar 3. No abstract available.

16.

Early changes in white matter pathways of the sensorimotor cortex in premanifest Huntington's disease.

Dumas EM, van den Bogaard SJ, Ruber ME, Reilman RR, Stout JC, Craufurd D, Hicks SL, Kennard C, Tabrizi SJ, van Buchem MA, van der Grond J, Roos RA.

Hum Brain Mapp. 2012 Jan;33(1):203-12. doi: 10.1002/hbm.21205. Epub 2011 Jan 24.

PMID:
21264990
17.

Simulating prosthetic vision: Optimizing the information content of a limited visual display.

van Rheede JJ, Kennard C, Hicks SL.

J Vis. 2010 Dec 29;10(14). pii: 32. doi: 10.1167/10.14.32.

18.

Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis.

Tabrizi SJ, Scahill RI, Durr A, Roos RA, Leavitt BR, Jones R, Landwehrmeyer GB, Fox NC, Johnson H, Hicks SL, Kennard C, Craufurd D, Frost C, Langbehn DR, Reilmann R, Stout JC; TRACK-HD Investigators.

Lancet Neurol. 2011 Jan;10(1):31-42. doi: 10.1016/S1474-4422(10)70276-3. Epub 2010 Dec 2.

PMID:
21130037
19.

Visual activation of extra-striate cortex in the absence of V1 activation.

Bridge H, Hicks SL, Xie J, Okell TW, Mannan S, Alexander I, Cowey A, Kennard C.

Neuropsychologia. 2010 Dec;48(14):4148-54. doi: 10.1016/j.neuropsychologia.2010.10.022. Epub 2010 Oct 23.

20.

Biological significance of EPHA2 expression in neuroblastoma.

Kung B, Zhao H, Hicks SL, Tang XX, Ikegaki N.

Int J Oncol. 2009 Oct;35(4):845-50.

21.

Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data.

Tabrizi SJ, Langbehn DR, Leavitt BR, Roos RA, Durr A, Craufurd D, Kennard C, Hicks SL, Fox NC, Scahill RI, Borowsky B, Tobin AJ, Rosas HD, Johnson H, Reilmann R, Landwehrmeyer B, Stout JC; TRACK-HD investigators.

Lancet Neurol. 2009 Sep;8(9):791-801. doi: 10.1016/S1474-4422(09)70170-X. Epub 2009 Jul 29.

22.

Saccadometry of conditional rules in presymptomatic Huntington's disease.

Robert MP, Nachev PC, Hicks SL, Golding CV, Tabrizi SJ, Kennard C.

Ann N Y Acad Sci. 2009 May;1164:444-50. doi: 10.1111/j.1749-6632.2008.03736.x.

PMID:
19645945
23.

Oculomotor deficits indicate the progression of Huntington's disease.

Hicks SL, Robert MP, Golding CV, Tabrizi SJ, Kennard C.

Prog Brain Res. 2008;171:555-8. doi: 10.1016/S0079-6123(08)00678-X.

PMID:
18718352
24.

Do a five-step financial check-up.

Hicks SL, Millbrook RL.

Mich Med. 2008 May-Jun;107(3):28-9. No abstract available.

PMID:
18700403
25.

White matter connections reflect changes in voluntary-guided saccades in pre-symptomatic Huntington's disease.

Klöppel S, Draganski B, Golding CV, Chu C, Nagy Z, Cook PA, Hicks SL, Kennard C, Alexander DC, Parker GJ, Tabrizi SJ, Frackowiak RS.

Brain. 2008 Jan;131(Pt 1):196-204. Epub 2007 Dec 3.

PMID:
18056161
26.

De novo identification of MIZ-1 (ZBTB17) encoding a MYC-interacting zinc-finger protein as a new favorable neuroblastoma gene.

Ikegaki N, Gotoh T, Kung B, Riceberg JS, Kim DY, Zhao H, Rappaport EF, Hicks SL, Seeger RC, Tang XX.

Clin Cancer Res. 2007 Oct 15;13(20):6001-9.

27.

The MYCN enigma: significance of MYCN expression in neuroblastoma.

Tang XX, Zhao H, Kung B, Kim DY, Hicks SL, Cohn SL, Cheung NK, Seeger RC, Evans AE, Ikegaki N.

Cancer Res. 2006 Mar 1;66(5):2826-33.

28.

Measurement of S-nitrosothiols in extracellular fluids from healthy human volunteers and rheumatoid arthritis patients, using electron paramagnetic resonance spectrometry.

Rocks SA, Davies CA, Hicks SL, Webb AJ, Klocke R, Timmins GS, Johnston A, Jawad AS, Blake DR, Benjamin N, Winyard PG.

Free Radic Biol Med. 2005 Oct 1;39(7):937-48.

PMID:
16140213
29.

What is your diagnosis? Intestinal adenocarcinoma.

Gardner CH, Hicks SL, Puette JR, Bunch SE.

J Am Vet Med Assoc. 2003 Sep 15;223(6):783-4. No abstract available.

PMID:
14507092
30.

The ingestion of inorganic nitrate increases gastric S-nitrosothiol levels and inhibits platelet function in humans.

Richardson G, Hicks SL, O'Byrne S, Frost MT, Moore K, Benjamin N, McKnight GM.

Nitric Oxide. 2002 Aug;7(1):24-9.

PMID:
12175816
31.

Electrophysiological evidence for vestibular activation of the guinea pig hippocampus.

Cuthbert PC, Gilchrist DP, Hicks SL, MacDougall HG, Curthoys IS.

Neuroreport. 2000 May 15;11(7):1443-7.

PMID:
10841354
32.

Ensuring the continuing competence of physician assistants.

DaVanzo JE, Hicks SL, Ruback TJ.

Acad Med. 1997 Dec;72(12):1028-9. No abstract available.

PMID:
9435703
33.

Standing guard against silent ischemia & infarction.

Hicks SL.

Nursing. 1994 Jan;24(1):34-9; quiz 40. No abstract available.

PMID:
8278100
34.

Open visiting policies in the ICU.

Hicks SL.

Am J Crit Care. 1993 Sep;2(5):432. No abstract available.

PMID:
8220680
35.

Cardiomyoplasty: treatment of the failing heart using the skeletal muscle wrap.

Stewart JV, Hicks SL, Leflar KM, Kaempf G, Bove LA, DiMarzio D.

J Cardiovasc Nurs. 1993 Jan;7(2):23-31. Erratum in: J Cardiovasc Nurs 1993 Oct;8(1):viii.

PMID:
7679437
36.

Fentanyl.

Hicks SL.

N C Med J. 1984 Jul;45(7):475-6. No abstract available.

PMID:
6589496
37.

Modern etiology of neurosis.

HICKS SL.

J Ky State Med Assoc. 1958 Jan;56(1):55-6. No abstract available.

PMID:
13491915

Supplemental Content

Loading ...
Support Center